rushed overlooked limited research funding peters worries lycopene lackluster performance date mean never progresses clinical trials situation leave millions consumers paying supplements not good not recommend lycopene based current evidence peters says not mean benefit important studies not similarly greg m. cole researcher university california los angeles sees great promise omega-3 fatty acids prevent alzheimer disease forms age related dementia expresses concern current clinical trials lack funding target promising patient population people not started signs problems risk alzheimer doubles years age 65 says got generation 75 million people heading not afford miss help prevention not find money study meantime patients